Imperial Brands delivers sixth consecutive year of growth

Imperial Brands

Imperial Brands plc (LON:IMB) has announced its full year report for the year ended 30 September 2026

Business highlights*

   Sixth consecutive year of broad-based growth; delivering on strategic priorities.

   Tobacco net revenue growth of 1.7% (reported tobacco revenue declined -5.0%).

   Next Generation Products net revenue up 11.4%, third year of market share growth in all three categories (reported NGP revenue growth +17.8%).

   Distribution adjusted operating profit up 4.1% reflecting recovery in Transport (reported operating profit up 2.0%).

   Adjusted operating profit up 3.7% (reported operating profit down 10.2%, reflecting strategic investments and Delaware settlement).

   Adjusted earnings per share up 8.8% driven by adjusted operating profit growth and share count reduction (reported earnings per share declined -3.3%, largely driven by operating profit).

   Strong cash generation, with free cash flow of £2.6bn.

   Increased capital returns: FY26 dividend per share up 4% and £1.5bn share buyback for FY27 commenced.

   Growing momentum behind transformation; on track to deliver at least £320m of annual cost savings by 2030.

* All measures at constant currency unless otherwise stated.

Financial summary

Twelve months ended30 September 2026 Reported  Adjusted2
 20262025Change 20262025ActualConstant currency3
Revenue£m31,67732,171-1.5% ––––
Tobacco & NGP net revenue1£m––– 8,5068,316+2.3%+2.1%
Tobacco & NGP operating profit£m2,8193,178-11.3% 3,7893,665+3.4%+3.7%
Operating profit£m3,1343,490-10.2% 4,1303,988+3.6%+3.7%
Earnings per shareP242.9251.1-3.3% 341.0315.0+8.3%+8.8%
Net debt£m(9,126)(8,954)– (8,786)(8,406)––
Dividend per shareP166.72160.32+4.0% 166.72160.32+4.0%+4.0%
  1. Tobacco & NGP net revenue is reported revenue less duty and similar items and sale of peripheral products and Distribution (Logista) revenue.
  2. See page 3 for the basis of presentation and the supplementary section at the end of the financial statements for the reconciliation between reported and adjusted measures.
  3. Constant currency removes effect of exchange rate movements on the translation of the results of our overseas operations.

Lukas Paravicini, Chief Executive Officer

“We continue to perform and transform. This is our sixth consecutive year of growth in tobacco & NGP net revenue and adjusted operating profit. In NGP, once again we grew net revenues at double digit and market share in all categories. At the same time, we have made tangible progress on our transformation to become more consumer-centric, agile, data led and efficient.

“In combustibles, we successfully managed market share, pricing and volumes to deliver sustainable, growing revenue and profit. Our long-term investments in brands and sales execution continue to drive growth in the US and Germany, our two largest markets, as well as broad-based delivery across other market clusters. In NGP our strong organic growth was supported by the acquisitions of Black Buffalo in the US and Helwit in Sweden.

“While continuing to invest in and build future consumer capabilities, underpinned by new technologies, we are confident of achieving at least £320 million of annual savings by 2030. We have delivered annualised savings of £90 million, with actions taken since the programme began supporting future annualised savings of £180 million – more than half of our target.

“Our strategy continues to deliver superior returns, with our FY26 share buyback of £1.45 billion completed, 4% annual growth in our dividend per share, and an increase in our share buyback for FY27 to £1.5 billion. Our expectations for the coming year are in line with our medium-term guidance.”

Operational highlights

Driving sustainable value in combustibles

   Strong performance across all key markets resulted in tobacco net revenue growth of 1.7%, driven by pricing of +5.1% offsetting volume declines of -3.4%

   Americas delivered strong tobacco net revenue growth of +3.3%, reflecting robust pricing and improving market volume dynamics

   Europe managed volume, value and share across the portfolio, with tobacco net revenue declining -0.5%; excluding private label, tobacco net revenue grew +0.4%, reflecting good execution in Germany and UK and strong performance from market clusters.

   AAACE, tobacco net revenue grew 2.9% reflecting strong performances in Africa, Asia Middle East & Turkey market clusters, offset by performance in Australia. Excluding Australia, tobacco net revenue in AAACE grew 7.6%

   Aggregate cigarette volume share across US, Germany, Spain, UK and Australia down –15bps, similar to position at half year

Building scale in Next Generation Products

   Multi-category approach delivering market share gains in all three categories and strong volume growth in all regions; another year of double-digit net revenue growth; growing profitability in Europe

   In modern oral, Zone in US continuing to deliver strong volume growth, with addition of Black Buffalo addressing complementary consumer segments; in Nordics new product launches in Skruf and Zone performing well and acquisition of Helwit expands our portfolio; in UK Zone growing share

   New pod-based blu bar and blu kit ranges performing well as markets continue to transition to rechargeable systems across Europe; growing market share in UK, France, Germany and New Zealand; double-digit market shares in UK, France and Spain.

   Heated product sales growing strongly, driven by Pulze 3.0 and new iD sticks, particularly in Italy, Poland, Czechia and Greece.

   New ‘Smokeless’ category from FY27, including both NGP and traditional oral nicotine delivery (TOND) business in Nordics; in FY26 TOND delivered £135 million net revenue and £77 million adjusted operating profit, equating to FY26 Smokeless category with £554 million net revenue and adjusted operating profit of £14 million

Progress on Transformation

   Confident of achieving at least £320m cost savings per annum by 2030

   Delivered £90m of annualised savings in FY26; actions taken since the transformation programme began support future annualised future savings of £180m

   Strong momentum behind manufacturing footprint rationalisation; completed consultation in Langenhagen

   Continuing to invest in our consumer capabilities and new technologies; Strategic partnership with Capgemini to support growth and deliver efficiencies: continued rollout of enterprise platforms. Go-live of our new ERP platform in Australasia and our Radom manufacturing facility in Poland

   During FY26, we completed programmes that will lead to a reduction of 2,100 roles globally, and we expect a further reduction of between 2,100 and 2,500 roles by the end of 2030. Throughout this transformation, we are committed to following appropriate consultation processes and supporting our people

Financial delivery*

Tobacco & NGP net revenue growth driven by resilient tobacco pricing

   Tobacco volumes down -3.4% (to 180.6bn SE) driven by declines in Europe, reflecting the planned reduction in German private label production due to the closure of the Langenhagen factory, together with market declines and improving market backdrop in the US and growth in our AAACE region

   Solid tobacco pricing of 5.1% delivered tobacco net revenue growth of 1.7%

   NGP net revenue up 11.4% as strong growth in Europe and AAACE more than offset declines in US as we withdrew our legacy myblu vape from the market

   Tobacco & NGP net revenue up 2.1%, driven by a broad base of markets

   Reported tobacco & NGP revenue declined -4.6%, reflecting lower excise taxes due to volume declines in high excise markets such as Australia and the UK, and the reduction in German private label production, partly offset by stronger tobacco volume in our AMET and African market clusters and NGP growth

Delivering growth in adjusted operating profit

   Group adjusted operating profit grew 3.7% on prior year, driven primarily by improved profitability in tobacco

   Reported operating profit declined -10.2% reflecting higher costs relating to the Delaware settlement charges and 2030 Strategy activities

   Tobacco adjusted operating profit increased 3.5%, driven by pricing offsetting volume declines and increased investment; reported tobacco operating profit declined -12.3% due to costs associated with the Delaware settlement and implementation of 2030 Strategy

   NGP adjusted operating loss of £63m, a £5m improvement on prior year, reflecting growing profitability in Europe, offset by the inclusion of Black Buffalo in the US; reported NGP operating losses declined £48m, reflecting, lower amortisation of intangibles and the impact of the fair value assessment of Auxly, offset by costs relating to transitioning myblu out of the US market

   Distribution adjusted operating profit including eliminations increased 3.1%, driven by an improvement in long-distance transportation

   Adjusted EPS grew by 8.8% reflecting an increase in earnings of 3.0% and reduced share count more than offsetting increased finance charges and higher tax and minority interest costs

   Reported EPS declined -3.3% as a result of lower operating profits due to the Delaware settlement and 2030 Strategy costs and higher financing costs offset by a lower tax charge and reduced share count due to the ongoing share buyback

Free cash flow supporting investment and shareholder returns

   Free cash flow of £2.6bn, reflecting adjusted operating cash conversion of c.102%

   Adjusted net debt £8.8bn (FY25: £8.4bn); adjusted net debt to EBITDA at 2.0x (FY25: 2.0x); reported net debt £9.1bn (FY25: £9.0bn).

   FY26 dividend per share up 4.0% to 166.72 pence, in line with our progressive dividend policy

   Ongoing, multi-year evergreen buyback: FY26 £1.45bn completed; £1.5bn underway for FY27, reflecting confidence in future performance

   Cumulative capital returns from FY21 to FY26 of over £13bn, representing over 21% of issued share capital since the buyback commenced in October 2022

* All measures at constant currency unless otherwise stated.

OUTLOOK

Our expectations for the coming year are in line with the medium-term guidance set out at our Capital Markets Day in March 2025. On a constant currency basis, we expect to deliver low-single-digit tobacco and double-digit NGP net revenue growth. Tobacco pricing will continue to more than offset cigarette volume declines and in NGP we will continue to focus on and invest in the most relevant profit pools in our accessible footprint, maintaining double digit growth through consumer-focused innovation and consumer acquisition. In FY27, we will combine our traditional oral nicotine and NGP net revenue and adjusted operating profit and refer to it as “Smokeless”.

For FY27, Group adjusted operating profit is expected to grow at a similar level to FY26, on a constant currency basis, primarily driven by continued profit growth from our combustible tobacco business. The usual second half weighting of performance is expected to be more pronounced than in FY26. Headwinds caused by disruption to our supply chain in Ukraine, the result of an attack on our facilities, will have a short-term impact during the first half of FY27, whilst the benefits of pricing, transformation efficiencies and duty drawback in the US will be weighted to the second half. 

After 2030 Strategy costs, including the closure of our Langenhagen factory during the year, and the second instalment of the Delaware settlement, we expect to generate free cash flow of at least £2.2 billion in FY27, in line with the guidance provided at the Capital Markets Day in March 2025. We expect FY27 to be a significant year for 2030 Strategy cash costs. Growth in adjusted operating profit combined with the impact of our ongoing share buyback is expected to result in at least high single-digit adjusted earnings per share for the full year. At current rates, foreign exchange translation is expected to be a headwind of 0.5% to 1.5% to net revenue, adjusted operating profit and earnings per share.

The geopolitical and macroeconomic backdrop continues to be uncertain, with the potential future impact of the Middle East conflict, on both costs and consumer behaviour, remaining difficult to assess. However, the power of our brands, depth of our portfolios and diverse growth levers across our global markets mean we are well placed to navigate any future volatility.

Share on:

Latest Company News

Imperial Brands delivers sixth consecutive year of growth

Imperial Brands reported 2.1% growth in tobacco and next-generation product net revenue to £8.5bn for FY26, marking its sixth...

Imperial Brands on track for FY26 guidance as £1.5bn share buyback announced

Imperial Brands expects to deliver FY26 guidance across all key metrics, including adjusted operating profit growth of 3% to...

Imperial Brands maintains FY26 guidance after mixed first half

Imperial Brands delivered higher adjusted earnings and strong cash generation in the first half of 2026, with continued growth...

Imperial Brands reports steady FY25 aperformance and higher shareholder returns

Imperial Brands delivered further progress in the year to 30 September 2025 with growth in tobacco and next generation...

Imperial Brands Plc confirms FY25 guidance, £1.45bn FY26 share buyback

Imperial Brands expects FY25 results in line with guidance, supported by growth in tobacco and NGP. The group has...

    Search